Hadassah

Galmed Pharma Names Hadassah’s Dr. Ran Oren as Chief Medical Officer

Friday, Aug 5 2016

Chief Medical Officer Dr. Ran Oren.

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development of a once-daily, oral therapy for the treatment of liver diseases, has named Prof. Ran Oren, head of the Hadassah Medical Organization’s Institute of Gastroenterology and Liver Disease, as its new Chief Medical Officer.

Having received his medical degree from the Hadassah-Hebrew University School of Medicine, as well as residency training in internal medicine, gastroenterology, and liver pathology at Hadassah, Prof. Oren also completed a fellowship in New York City, combining research at Albert Einstein College of Medicine and advanced clinical fellowship at the Liver Division of Mount Sinai Medical Center. In 2000, Dr. Oren established the Liver Unit at the Tel Aviv Sourasky Medical Center, where he also served as Chief of Medicine from 2008 to 2010. Dr. Oren concurrently served as the President of the Israeli Association for the Study of the Liver between 2007 and 2010.  In 2010, he became head of Hadassah’s Institute of Gastroenterology and Liver Disease.

A scientific collaborator of the late Prof. Tuvia Gilat, Co-founder of Galmed, Prof. Oren has served as a member of Galmed’s Scientific Advisory Board since 2014. Prof. Oren was the principal investigator of Aramchol's Phase IIa study, reports Allen Baharaff, Galmed's President and Chief Executive Officer, “and we are privileged that he has agreed to join Galmed and lead the clinical development of Aramchol."

Prof. Oren notes: "I am honored to continue the life work of Prof. Gilat, who was my mentor and friend for many years. I have been scientifically and clinically involved in the field of NAFLD (non-alcoholic fatty liver disease) since the early 2000’s. I view this position at Galmed as an exciting opportunity for me to contribute to a company that I have been following from concept to this exciting phase of advanced clinical studies, and I look forward to working with the Galmed team."

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Mar 22 2017

Marathon Runner Pays Tribute to Hadassah Medical Team

After successfully running in the 2017 Jerusalem Marathon, Gil Troy pays tribute to Prof. Meir Liebergall, Director of the Hadassah Medical Organization’s Orthopedic Surgery Department, and his medical team, who made this run possible.

READ MORE ›
alt_text

Wednesday, Mar 22 2017

Reversing the Odds with Technology and Expertise

It could be a young patient with a virulent flu. Or a man having a severe asthma attack. Or a pregnant woman with a complication of pregnancy.

READ MORE ›
alt_text

Wednesday, Mar 22 2017

Cypriot Health Minister Helps Save Israeli Patient

Whether it was a newborn baby with a severe heart defect or a pregnant woman with an unusual ectopic pregnancy, the Hadassah Medical Organization has been known to save the lives of Cypriot patients by helicoptering them to its hospital for complex emergency treatments. Recently, however, it was the Cypriot Health Minister who helped save the life of an Israeli patient.

READ MORE ›
alt_text

Wednesday, Mar 22 2017

Top-Tier Turkish Journalists Receive Inside View of Hadassah Hospital

A delegation of top-tier Turkish journalists, accompanied by representatives from the Israel Foreign Ministry, visited Hadassah Hospital Ein Kerem this month, marking the first time a high-level Turkish delegation has come to Israel since the new reconciliation agreement was signed between Israel and Turkey.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More